In this report we summarize what is known about the molecular biology of the hepatitis-B viruses. In the first part we describe the general properties of these viruses, their structure and their replication strategy. In the second part we discuss the most recent attempts at the establishment of tissue culture systems allowing the study of the virus/host cell interactions in vitro. In addition we present experimental data from our laboratory in which we show that new synthesis of viral proteins can be studied in vitro either by biochemical analysis of already infected cells or after experimental infection.
INTRODUCTION
The hepatitis-B viruses are enveloped viruses with a partially double-stranded DNA genome which are combined in the group of the hepadna viridae (Robinson et al. 1981) . The most important member of the hepadna virus group is the human pathogenic hepatitis-B virus (HBV) (Dane et al. 1970) . In addition, three animal hepatitis-B viruses have been described in detail. These are the woodchuck hepatitis-B virus (WHV), the ground squirrel hepatitis-B virus (GSHV), and the duck hepatitis-B virus (DHBV) (Summers, 1981) . Characteristic of this virus group is the very narrow host range, the distinct organ tropism, and the replication strategy which includes reverse transcription of an RNA pregenome.
In man, infection with HBV after a long incubation period of several months often results in a severe liver disease. While most of the patients recover completely, the infection becomes chronic in about 10% of those affected depending on their age. Generally, the younger the patients the higher is the proportion of those entering the chronic course. The effects of sustained HBV infection vary considerably. While most of the chronic carriers are in good health, a significant percentage shows signs of chronic active hepatitis with sporadic jaundice.
However, all chronically infected persons are at high risk of developing liver cancer or liver cirrhosis. Thus, HBV is one of the few viruses which has been linked to human cancer. Consequently, in the Far East, where HBV is endemic and a large proportion of the newborn become infected, liver cancer due to chronic HBV infection is a major cause of death. With an estimated 200 million people being persistently infected with HBV worldwide the importance of research on this virus is evident.
H.-jf. Schlicht, P. Galle and H. Schaller In this report we will briefly summarize what is known about the molecular biology of the hepatitis-B viruses. The first part will deal with the general properties of this virus group describing the viral structure and its replication strategy. In the second part we will discuss the most recent attempts at the establishment of tissue culture systems allowing the study of the virus/host cell interactions in vitro. For additional information the reader is referred to two recent comprehensive review articles (Tiollais et al. 1985; Howard, 1986 ).
M OLECULAR BIOLOGY OF H EPATITIS-B VIRUSES
As has been already mentioned, the hepatitis-B viruses show a distinct organ tropism. Primarily it is the liver which is infected and in which the virus replicates. However, other tissues, such as the pancreas (Halpern et al. 1984) or certain cells of the immune system (Elfassi et al. 1984) , may also be affected to a minor extent.
Morphologically the hepatitis-B viruses resemble other enveloped viruses (Fig. 1 ). In the case of HBV the infectious particle, the so called Dane particle (Dane et al. 1970) , has a diameter of about 42 nm and consists of a core, which contains the viral nucleic acid, and a lipid envelope. Associated with this envelope are three structurally related proteins which are partially glycosylated. These proteins, which are called the S and pre-S proteins, share the same C-terminal domain but possess different A^-terminal extensions (see below).
In contrast to most other enveloped viruses the viral surface proteins are not inserted into the outer membrane of the infected cell. Consequently, budding of newly synthesized virus appears to take place at the endoplasmic reticulum and not at the outer membrane (Eble et al. 1986; Patzer et al. 1986) .
As has been reported recently, one of the HBV surface proteins may interact with a cellular receptor present on hepatocytes, the target cells of the hepatitis-B viruses (Neurath et al. 1986 ). However, interaction with a specific cellular receptor can not solely explain the tissue tropism of HBV because to date it has not been possible to achieve replication of the virus in non-liver cells after transfection of cloned viral DNA (see below).
For unknown reasons during the infection cycle the viral envelope proteins are synthesized in a large excess and are secreted as lipid-containing particles into the serum. These particles, which are devoid of viral nucleic acid, are referred to as S-particles or HBsAg. HBsAg is usually detected during the first phase of acute illness in the serum of infected persons. If a patient remains HBsAg positive for more than 6 months this is taken as indicating the establishment of a chronic carrier state. From the serum of such chronically infected persons surface antigen particles can be isolated for decades and in the past this was the only source of viral antigens for vaccine preparation. Very recently, a vaccine prepared from HBV surface antigen expressed in yeast by recombinant DNA technology has been licensed and it can be expected that this preparation will replace the serum derived material in the near future (Grist & Mandal, 1986) .
The viral core appears to consist of only one protein which is called the core antigen (HBcAg). In the case of HBV, this protein has a molecular weight of about 21x103M t and consists of 183 amino acids with 180 copies of this protein forming one viral core (Feitelson et al. 1982; Onodera et al. 1982; Petit & Pillot, 1985) . Interestingly, viral core protein and viral cores are not only found in the cytoplasm but can also be detected in considerable amounts in the cell nucleus (Gudat et al. 1975; Ray et al. 1976 and unpublished data from this laboratory). This may be the consequence of a transport mechanism by which viral genomes, which have been synthesized within cores in the cytoplasm, are imported into the nucleus (see below).
A feature of the HBV core protein is its ability to form ordered aggregates also outside its natural host cell. Thus, after expression of this protein in Escherichia coli (Cohen & Richmond, 1982; Stahl et al. 1982) , Bacillus subtilis (Hardy et al. 1981) , or yeast cells (Miyanohara et al. 1986 ), particles can be isolated which are morphologically and serologically identical to the viral cores isolated from HBVinfected liver tissue.
Besides the full length HBV core protein a truncated form with a molecular weight of about 16X 103M r, which is called the HBeAg, may also be detected in serum and liver of HBV-infected individuals. This protein, which has lost the ability to aggregate into core particles, lacks the C-terminal 34 amino acids present in the 21Xl03Mr core protein (Takahashi et al. 1983) . It can be easily distinguished by immunological methods from the untruncated core protein because due to a different conformation a antigenic determinant (HBe2) which is recognized by specific antibodies is only accessible in the HBeAg (Salfeld, 1985) . Proteins analogous to the HBeAg may also be produced during infection with other hepadna viruses (Feitelson et al. 1982; Hantz et al. 1983 and unpublished data from this laboratory).
The physiological significance of the synthesis of a soluble truncated form of the core protein is unknown. Preliminary data indicate that there are two different processing pathways for the HBV C-gene products. While in one biosynthetic pathway the 21x103Mr core protein is synthesized free in the cytoplasm where it aggregates to form viral cores, in the other pathway it may be synthesized like a secretory protein at the endoplasmic reticulum. Proteolytic processing then may result in a truncated protein which eventually is secreted (Roossinck et al. 1986; Ou et al. 1986; Uy et al. 1986 ; and unpublished data from this laboratory). Such an alternative processing pathway has already been described for the core protein of the Moloney murine leukemia virus (Tung et al. 1976; Pillemer et al. 1986) .
The core encloses the viral genome which has a peculiar structure. It consists of a circular, partially double-stranded DNA with a length of about 3 kb. The minus strand is slightly longer than a single genome length and contains a terminal redundancy of several nucleotides. The plus strand is of variable length and spans the interruption in the minus strand which continues to exist after formation of the circular molecule due to the terminal redundancy of the minus strand. At the 5' end of the minus strand a protein molecule is covalently bound (Gerlich & Robinson, 1980; Molnar-Kimber et al. 1983) . Whether this protein is encoded by the virus or by the host cell is unknown. This genome-linked protein is believed to function as a primer during genome replication (see below).
Besides the viral genome a DNA-polymerase was also found to be associated with the viral core. This enzyme was first defined as an enzymatic activity which incorporated nucleotides in vitro into the genomic gap region (Kaplan et al. 1973) . Later it could be shown that with respect to its biosynthetic characteristics this enzyme resembles known retroviral reverse transcriptases (Summers & Mason, 1982) .
Several isolates of all four different hepatitis-B viruses have been sequenced (see Okamoto et al. 1986 and Cattaneo et al. 1986 for discussion of HBV sequences, Galiberteit al. 1982 and Kodamaei al. 1985 for WHV sequences, Seegerei al. 1984a for GSHV, and Mandart et al. 1984 and Sprengel et al. 1985 for DHBV). The gross structure of the HBV genome is shown in Fig. 2 . Characteristic of all hepatitis-B virus genomes is the very compact structure with extensively overlapping open reading frames (ORF). The C-frame encodes the viral core protein and overlaps with another ORF which is called the P-frame because the proposed gene product contains a homology to known reverse transcriptases and therefore is believed to encode the viral DNA polymerase (Toh et al. 1983) . This genomic arrangement is reminiscent to certain retroviruses and retrotransposons which also show a C/Pol overlap and which appear to synthesize their polymerase via a C/Pol fusion protein which then is proteolytically processed (see Hull & Covey, 1986 for a recent review). It seems likely that the same mechanism is used by the hepatitis-B viruses. Thus far, however, despite considerable efforts no P-frame products could be detected in acutely infected liver specimens and purified virus preparations (unpublished data from this laboratory).
Completely overlapping with the P-frame is the preS/S-frame which encodes the viral envelope proteins. Historically, this ORF is split into two parts, the S-and the pre-S region, with the pre-S region being further split into the pre-Sl and the pre-S2 region. The preS/S ORF encodes the three different HBV surface proteins which are called the S-protein, the pre-Sl protein and the pre-S2 protein. In HBV the Sprotein is 226 amino acids long and is encoded by the S-region alone. The pre-S2 protein is encoded by the S-and pre-S2 region and therefore contains 55 additional amino acids at its Af-terminus. The pre-Sl protein is encoded by the whole preS/S ORF and therefore, compared to the S-protein, contains 163 additional TV-terminal amino acids (Heermann et al. 1984; Tiollais et al. 1985; Pfaff el al. 1986 ).
In HBV, WH V and GSHV a fourth ORF overlapping both the P-and the C-frame is encountered, which, as its relevance is still unclear, is called the X-frame. This ORF is absent in the DHBV genome and therefore seems not to represent a gene essential for hepadna viruses. Based on a computer analysis of the codon usage it has been suggested that the X-ORF may be of cellular origin (Miller & Robinson, 1986) and, as its position within the viral genome is the same as for oncogenes found in the genomes of the rapidly transforming retroviruses, it has been speculated that the Xgene product may be involved in HBV induced tumorgenesis. Data supporting these speculations, however, are missing. That the X-frame is expressed during HBV and GSHV infection is indicated by the presence of antibodies directed against X-region encoded protein sequences in the serum (Kay et al. 1985; Moriarty et al. 1985; Meyers et al. 1986; Elfassi et al. 1986; Persing et al. 1986 and data from this laboratory). 
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II.-J. Schlicht, P. Galle and H. Schaller For all the four viruses described here the major transcripts have been mapped and found to be unspliced (Cattaneo et al. 1984; Biischer et al. 1985; Moroy et al. 1985; Enders et al. 1985; Will et al. 1987) . For HBV the transcripts are shown in Fig. 2 . The short 2-1 kb mRNA initiates within the pre-S region and encodes the major viral surface protein and the pre-S2 protein. The large 3-5 kb mRNA has more than genome length and is of central importance because it represents the template for reverse transcription. In addition, this 3-5 kb mRNA is believed to encode the viral core protein and the polymerase. It also may encode the pre-Sl protein, in which case however, internal initiation must occur.
Little is known about transcriptional regulation (see Tiollais et al. 1985 for discussion of available data). While the short RNA is synthesized in many cell types, synthesis of the large mRNA appears to be more restricted. There is evidence that a viral enhancer element influences the synthesis of the large mRNA in a tissue specific manner (Shaul et al. 1985) . However, it seems likely that differential enhancer activity is not the only reason for the hepatitis-B virus tissue tropism.
As already mentioned, the large mRNA serves as a template for synthesis of a new viral genome via reverse transcription. This step is a key event during the viral replication cycle (see also Summers & Mason, 1982; Lien et al. 1986; Will et al. 1987, and Seeger et al. 1986 for additional information). As outlined in Fig. 3 , this cycle begins with the entry of the virus into the target cell. After the uncoating process the viral genome is repaired in the nucleus to form a covalently closed circular molecule which then is used as a template for transcription. While the small transcript functions as a normal mRNA, the long transcript is not only translated into viral proteins but also serves as the template for the synthesis of a new viral genome. This process is believed to start with the encapsidation of this pregenomic RNA into a viral core, the core protein being encoded by the RNA itself. DNA synthesis then may be primed by the protein which is later found covalently bound to the 5' end of the newly synthesized DNA strand. During synthesis of the minus-strand DNA the RNA template is degraded. A small fragment at the RNA's 5' end, however, remains intact and is used for priming the synthesis of the plus strand by hybridizing to a partially complementary sequence present on the minus strand. For unknown reasons, synthesis of the plus-strand DNA ceases after a certain time and therefore a gap of variable length remains. It is conceivable that termination of the plus-strand synthesis coincides with the budding of the virus and thus may be due to the depletion of nucleotides.
While for a long time it was assumed that reverse transcription is an uncommon event occurring only in cells infected with retroviruses, during the last few years many genomic elements like for example copia in Drosophila or the Ty elements of yeast have been characterized which all appear to multiply by reverse transcription (see Baltimore, 1985; Hull & Covey, 1986 for reviews) . This raises the question how reverse transcription of normal cellular mRNAs is prevented in cells where active reverse transcriptase is present. It seems plausible that uncontrolled reverse transcription of cellular RNAs should be harmful for the cell although such a detrimental effect has not been demonstrated yet. That, in rare cases, reverse transcription of cellular mRNAs occurs is suggested by the detection of several pseudogenes in mammalian genomes which appear as DNA copies of completely or partially processed mRNAs (see for example Arsdell et al. 1981, and Wilde et al. 1982) .
A simple mechanism for prevention of copying cellular RNAs would be the immediate encapsidation of newly synthesized reverse transcriptase into the viral cores or, as for example in the case of copia or Ty, into core-like structures. If so, synthesis of the viral reverse transcriptase as a C/Pol precursor fusion protein would be of great advantage because, if this protein is incorporated into the nascent cores, the polymerase can be encapsidated before proteolytic activation. However, to date in the case of the hepatitis-B viruses such C/Pol fusion proteins, which are well characterized for retroviruses, have been found only in some HBV-related liver tumours .
Recent data, which were obtained for DHBV, demonstrate that most of the covalently closed circular viral DNA molecules present in the nucleus are syn thesized by reverse transcription (Tuttlemanei al. 1986b) . Consequently, uncoating of viral cores must occur inside the cell releasing both, newly synthesized viral DNA and active reverse transcriptase. Interestingly, preliminary data from this laboratory indicate, that the affinity of the DHBV reverse transcriptase for the DHBV template is very high (G. Radziwill et al. in preparation) . Thus, the inability of the viral polymerase to switch to another template could be another mechanism which prevents unspecific reverse transcription.
EXAMINATION OF HEPATITIS-B VIRUSES IN TISSUE CULTURE
As the data presented above demonstrate, research on hepatitis-B viruses benefited enormously from the advances in molecular biological techniques during the last few years. However, still very little is known about the interactions of these viruses with their host cells. The main reason for this deficiency has been the lack of an efficient and convenient tissue culture system allowing to propagate the virus in vitro. However, recent progress in establishing such an in vitro system may change the situation in the near future.
In an attempt to circumvent the lack of an in vitro system, animal experiments were performed, either using the natural hosts Seeger et al. 1984b; Sprengel et al. 1984) or transgenic mice (Chisari et al. 1985; Babinet et al. 1985) . In the first set of experiments Seeger et al. 19846; Sprengel et al. 1984) , cloned and sequenced viral DNA was injected intrahepatically; the DNA was in a recircularized form or in a head to tail tandem arrangement and was injected either as a calcium phosphate precipitate, a dextran precipitate, or dissolved in an isotonic phosphate buffer. All preparations of viral DNA proved to be infectious if injected directly into the liver but were not infectious if injected intravenously. Thus, these experiments proved that the cloned and sequenced viral genomes were functionally intact and that no viral proteins are necessary for initiation of viral infection. In addition, these experiments showed that there is apparently no risk for laboratory workers who handle recombinant viral DNA becoming infected with HBV. Currently the animal systems described above are being used for testing the infectivity of viral mutants constructed by recombinant DNA technology. However, for the study of HBV a major drawback lies in its very limited host range which besides man only includes chimpanzees, an endangered species with limited availability.
In the second set of experiments (Chisari et al. 1985; Babinet et al. 1985) incomplete HBV genomes were used to generate transgenic mice. These experiments were designed to mimic the chronic carrier state of HBV infection which is characterized by expression of large amounts of viral surface proteins. For this reason the HBV constructs employed were complete with respect to the surface antigen encoding regions but other parts were deleted. During these experiments transgenic animals expressing large amounts of HBV surface antigen were generated; these animals appeared to be healthy during the observation period (up to six months).
By using this approach, many important experimental questions, e.g. dealing with the viral tissue tropism, can be addressed. However, the sophisticated technique employed and the long period of time which passes before a final result can be obtained limits its application.
As both types of experiments discussed above show, the experimental approaches which can be followed by performing animal experiments are limited. Thus, there have been many attempts to achieve HB V replication in vitro either after transfection of cells with cloned viral DNA (Hirschman et al. 1980; Hirschman & Garfinkel, 1982; Wang et al. 1982; Cattaneo et al. 1983; , using HeLa cells, mouse fibroblasts, or Cos cells, or by infection of human foetal or adult hepatocytes with the virus itself (Brighton et al. 1971; Noyes, 1973; Hirschman & Garfinkel, 1980; Lindberg et al. 1985) . However, in all cases virus production was either absent or not reproducible.
These results were generally ascribed to the fact that hepatitis-B virus replication only takes place in specialized tissues, mainly the liver, and therefore is dependent on a very well differentiated status of its target cell. Because such a highly differentiated status might be lost rapidly during tissue culture, the above experiments were repeated using freshly prepared primary liver cells. As it is difficult to obtain such cells from human sources, the duck system was used in recent experiments performed by us and others (Tuttleman et al. 1986a; Tuttleman et al. 19866; Schlicht et al. 1987 ; and unpublished data from this laboratory).
For these experiments hepatocytes from congenitally infected, as well as from uninfected, ducks were obtained either after simple collagenase digestion of liver tissue or after liver perfusion. These cells were then employed for study of the duck hepatitis-B virus (DHBV) structural proteins and replication mechanism.
It was shown by Tuttleman and her colleagues as well as by us (Tuttleman et al. 1986a; Galle et al. in preparation) , that infection of primary duck liver cells with DHBV can be achieved in vitro. Successful infection, however, appeared to be highly dependent on the differentiated status of the liver cells because after 7 days in culture under usual conditions infection was no longer feasible. Furthermore, the results indicated that the time course of DHBV replication is relatively slow, the first detectable virus being released from the cells 4 to 8 days after infection.
During these examinations Tuttleman and co-workers also obtained convincing evidence that the covalently closed circular viral DNA, the transcriptionally active viral DNA located in the nucleus, is highly amplified during the infection process, and that this amplification occurs via reverse transcription and not by semiconserva tive replication (Tuttleman et al. 19866) . As has been already discussed above, this finding raises the question how reverse transcription of viral RNA can be permanently separated from the nucleic acid metabolism of the host cell.
While Tuttleman and her colleagues mainly studied biosynthesis of viral nucleic acids, we have been concentrating on examination of viral protein biosynthesis. In order to test whether primary duck liver cells are suited to the examination of DHBV protein biosynthesis at all, hepatocytes were obtained by simple collagenase digestion of liver tissue taken from congenitally infected ducks (Schlicht et al. 1987) . The cellular proteins were labelled immediately by incubation of the cell suspension with H.-jf. Schlicht, P. Galle and H. Schuller [3aS] methionine and examined for newly synthesized viral proteins by immuno précipitation with specific antisera. Using this technique, newly synthesized viral surface and core protein could be easily detected (Fig. 4) . These data showed for the first time, that it is possible to study the biosynthesis of DHBV proteins in its natural host cell.
However, this procedure only allowed us to examine 'run off' protein biosynthesis and only cells already infected with the virus could be used. Therefore, in order to optimize this system, in later experiments hepatocytes obtained after liver perfusion were employed. By using a highly supplemented medium, these cells could be kept in culture as a monolayer for several weeks without losing their competence for DHBV infection. Thus, these cells were ideally suited for study of viral protein synthesis after in vitro infection. Some results of such an in vitro infection experiment are shown in Fig. 5(A) to (C). As shown by Fig 5(A) and 5(B) viral core protein could be detected three to five days after infection. The amplification of viral DNA due to the infection process is demonstrated by Fig. 5(C) . Taken together these data show that it is possible to examine the fate of viral proteins and viral DNA after in vitro infection if well differentiated hepatocytes are used.
The results discussed above demonstrate that examination of hepatitis-B virus replication and protein biosynthesis in tissue culture is generally possible if primary hepatocytes are used. However, there are two major drawbacks to this experimental approach. First, the need to use primary cells is somewhat inconvenient because such cells are not always available, can not be stored, and must be used within a short period of time. Second, it is, at least, questionable whether such a system can be established for the study of the human virus. Therefore, we and others have tried to achieve HBV replication by using permanent cell lines. Very recently, two different systems proved to be suitable for production of HBV in vitro as was demonstrated by the isolation of viral particles from the culture medium. In one approach, the human hepatoma cell line HepG2 was used in an attempt to raise stable HBV-producing cell clones after cotransfection of cloned viral DNA with a dominant selection marker (Sureau et al. 1986 ). In another approach, which was used by us in cooperation with a Chinese group, a transient expression system which also used hepatoma cell lines of human origin was employed (Chang et al. 1987) . With this system it was also possible to examine biosynthesis of viral proteins after labelling with 35S-methionine and subsequent immunoprecipitation of viral proteins using specific antisera.
Which system will prove to be more convenient for systematic examinations remains to be seen. While, in general, stable cell lines have the advantage that the products of interest are synthesized in a relatively high amount, selection and expansion of such lines is very time consuming, taking several weeks before selected clones can be subjected to biochemical analysis. By transient expression, however, final results can be obtained in most cases within a few days. Thus, if the signals obtained after transient expression are strong enough, this system appears to be the method of choice.
In summary, the experimental data presented in the second part of this review imply that in the near future a wealth of new information about the molecular biology of the hepatitis-B viruses will be obtained by use of these newly described tissue culture systems. 
